SLC52A2 and glioblastoma: We thus identified that SLC52A2 acted as a detrimental prognostic factor in ACC (OS, DSS, PFI), CESC (OS, PFI), GBM (OS, DSS), KIRC (OS, DSS, PFI), KIRP (OS, DSS, PFI), LGG (OS, DSS, PFI), LIHC (OS, DSS), MESO (OS, DSS, PFI), PRAD (PFI), SARC (OS, DSS), SKCM (PFI), THYM (DSS), UCS (PFI) and UVM (OS, DSS, PF).